Odyssey Health (ODYY) Gross Margin (2014 - 2016)

Odyssey Health (ODYY) reported Gross Margin of 24.43% for Q3 2016, down 59.28% sequentially from 60.0% in Q2 2016.

Odyssey Health (ODYY) Gross Margin (2014 - 2016) Analysis & Trends

Odyssey Health has disclosed Gross Margin across 3 years of filings, most recently posting 24.43% for Q3 2016.

  • Quarterly Gross Margin changed N/A year-over-year to 24.43% in Q3 2016, while the trailing twelve-month figure through Apr 2017 was 24.43% (down 3557.0% YoY) and the FY2016 annual result came in at 45.8%, up 3463.0% from the prior year.
  • Gross Margin fell to 24.43% in Q3 2016, from 60.0% in the prior quarter.
  • Across five years, Gross Margin topped out at 60.0% in Q2 2016 and bottomed at 10.28% in Q4 2014.
  • The 3-year median for Gross Margin is 12.22% (2015), against an average of 23.83%.
  • The widest YoY moves for Gross Margin: up 4778 bps in 2016, down 4778 bps in 2016.
  • Odyssey Health's Gross Margin stood at 10.28% in 2014, then gained by 19 bps to 12.22% in 2015, then soared by 100 bps to 24.43% in 2016.
  • According to Business Quant data, Gross Margin over the past three periods registered 24.43%, 60.0%, and 12.22% for Q3 2016, Q2 2016, and Q2 2015 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 56.20%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 63.29%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 63.83%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 78.01%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 45.22%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 62.95%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 38.53%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 43.89%
10 Odyssey Health - - - -

Historic Data

Download Data
DateValue
Jul 31, 2016 24.43%
Apr 30, 2016 60.00%
Apr 30, 2015 12.22%
Jan 31, 2015 12.20%
Oct 31, 2014 10.28%